AEMD Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own AEMD shares is 18, representing 3.09% of the company's common stock.

TWO SIGMA INVESTMENTS, LP, in the last quarter, reduced its stake in AEMD by -19.42% restricting it's holding to 43.15 thousand shares of worth nearly $9.74K. ADVISOR GROUP HOLDINGS, INC. also lessened -30.49% of the AEMD shares from its portfolio, reducing its holding to 3.99 thousand shares of worth $898.00. PNC FINANCIAL SERVICES GROUP, INC. also shunned AEMD shares holding by -2.06% last quarter which brought its holding to 667 shares worth $151.00.

As per its latest 13F filing, GEODE CAPITAL MANAGEMENT, LLC increased its stake in AEMD by 19.67% in the last quarter. The institutional holder raised its holding to 202.76 thousand shares having worth more than $42.78K. TWO SIGMA SECURITIES, LLC also added 31.12% more shares of AEMD to its portfolio, raising its holding to 23.79 thousand shares of worth $5.37K. TOWER RESEARCH CAPITAL LLC (TRC) also increased its AEMD shares holding by 0.06% which brought its holding to 8.54 thousand shares worth $1.93K.

The insider with the most stakes in AEMD is BROENNIMAN EDWARD G , director at the company. Additionally, AEMD stock is highly held by director BARRY FRANKLYN S JR and director Shah Chetan among others.

Company executives, directors, and other insiders own 0.54% percent of Aethlon Medical, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which AEMD insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SHAH CHETAN, BROENNIMAN EDWARD G, and BARRY FRANKLYN S JR.

There have been 0 transaction(s) during the past 6-months in which Aethlon Medical, Inc. insiders have bought stock, totalling 0 shares

Around 0 Aethlon Medical, Inc. shares are held by insiders, which represents about 0.54% of AEMD stock.

AEMD director, BROENNIMAN EDWARD G holds the largest portfolio of the company's shares. AEMD shares owned by BROENNIMAN total nearly 282.17 thousand.

is the largest institutional owner in AEMD which holds 267 shares worth $60.00 or 0% of the total AEMD shares outstanding followed by GEODE CAPITAL MANAGEMENT, LLC with ownership of 202.76 thousand shares representing 0.83% of the AEMD ownership. BLACKROCK INC. is the third largest stakeholder with 73.83 thousand shares or 0.3% of the ownership worth more than $16.67K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the AEMD is concerned, it is a stock which is not optionable.

Number of AEMD shares short is 286.15K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 13.96M shares of AEMD are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, AEMD has 13.84M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for AEMD is 0.98.